Cart
sales@molnova.com
STM2120
CAS No. 2762286-04-2
STM2120( —— )
Catalog No. M37151 CAS No. 2762286-04-2
STM2120 is a potent METTL3 inhibitor (IC50: 64.5 μM) with inhibitory effect on METTL14.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 400 | In Stock |
|
| 5MG | 630 | In Stock |
|
| 10MG | 1007 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1950 | In Stock |
|
| 100MG | 2583 | In Stock |
|
| 500MG | 5184 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSTM2120
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTM2120 is a potent METTL3 inhibitor (IC50: 64.5 μM) with inhibitory effect on METTL14.
-
DescriptionSTM2120 is a METTL3-METTL14 inhibitor with an IC50 of 64.5 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2762286-04-2
-
Formula Weight333.34
-
Molecular FormulaC18H15N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (299.99 mM; Ultrasonic (<80°C)
-
SMILESO=C1C=C(N=C2C=CC=CN12)C(=O)NCC=3N=C4C=CC=C(N4C3)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yankova E, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021 May;593(7860):597-601.?
molnova catalog
related products
-
Dok-4 (263 - 275)
Dok-4 (263 - 275)
-
BCMA72-80
BCMA72-80 is a HLA-A2-specific B-cell maturation antigen (BCMA) peptide, with a strong affinity to HLA-A2. It is used to used in the research of multiple myeloma or other B-cell maturation antigen expressing tumors.
-
PPIase-Parvulin Inhi...
PPIase-Parvulin Inhibitor is a cell-pemeable inhibitor of the Pin1 and Pin4.
